Copyright Reports & Markets. All rights reserved.

Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Inhalable Insulin
    • 1.4.3 Oral Insulin
    • 1.4.4 Insulin Patches
    • 1.4.5 CGM Systems
    • 1.4.6 Artificial Pancreas
  • 1.5 Market by Application
    • 1.5.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostic/Clinics
    • 1.5.3 ICUs
    • 1.5.4 Home Healthcare
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2015-2026)
  • 2.2 Global Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Regions
    • 2.2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Share by Regions (2015-2020)
    • 2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Next Generation Diabetes Therapy and Drug Delivery Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Next Generation Diabetes Therapy and Drug Delivery Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Market Size
    • 3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2015-2020)
    • 3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
    • 3.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2019
  • 3.3 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
  • 3.4 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
  • 3.5 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2015-2020)
  • 4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
  • 5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
  • 6.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in North America (2019-2020)
  • 6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
  • 6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
  • 7.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Europe (2019-2020)
  • 7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
  • 7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

8 China

  • 8.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
  • 8.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in China (2019-2020)
  • 8.3 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
  • 8.4 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
  • 9.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Japan (2019-2020)
  • 9.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
  • 9.4 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
  • 10.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

11 India

  • 11.1 India Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
  • 11.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in India (2019-2020)
  • 11.3 India Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
  • 11.4 India Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
  • 12.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
  • 12.4 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Johnson & Johnson
    • 13.1.1 Johnson & Johnson Company Details
    • 13.1.2 Johnson & Johnson Business Overview
    • 13.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020))
    • 13.1.5 Johnson & Johnson Recent Development
  • 13.2 Abbott Laboratories
    • 13.2.1 Abbott Laboratories Company Details
    • 13.2.2 Abbott Laboratories Business Overview
    • 13.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.2.5 Abbott Laboratories Recent Development
  • 13.3 Medtronic
    • 13.3.1 Medtronic Company Details
    • 13.3.2 Medtronic Business Overview
    • 13.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.3.5 Medtronic Recent Development
  • 13.4 Sanofi
    • 13.4.1 Sanofi Company Details
    • 13.4.2 Sanofi Business Overview
    • 13.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.4.5 Sanofi Recent Development
  • 13.5 Novo Nordisk
    • 13.5.1 Novo Nordisk Company Details
    • 13.5.2 Novo Nordisk Business Overview
    • 13.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.5.5 Novo Nordisk Recent Development
  • 13.6 MannKind Corporation
    • 13.6.1 MannKind Corporation Company Details
    • 13.6.2 MannKind Corporation Business Overview
    • 13.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.6.5 MannKind Corporation Recent Development
  • 13.7 Enteris BioPharma
    • 13.7.1 Enteris BioPharma Company Details
    • 13.7.2 Enteris BioPharma Business Overview
    • 13.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.7.5 Enteris BioPharma Recent Development
  • 13.8 Dexcom
    • 13.8.1 Dexcom Company Details
    • 13.8.2 Dexcom Business Overview
    • 13.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.8.5 Dexcom Recent Development
  • 13.9 Senseonics
    • 13.9.1 Senseonics Company Details
    • 13.9.2 Senseonics Business Overview
    • 13.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.9.5 Senseonics Recent Development
  • 13.10 Medtech
    • 13.10.1 Medtech Company Details
    • 13.10.2 Medtech Business Overview
    • 13.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 13.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 13.10.5 Medtech Recent Development
  • 13.11 Synertech
    • 10.11.1 Synertech Company Details
    • 10.11.2 Synertech Business Overview
    • 10.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 10.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 10.11.5 Synertech Recent Development
  • 13.12 Zosano Pharma
    • 10.12.1 Zosano Pharma Company Details
    • 10.12.2 Zosano Pharma Business Overview
    • 10.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 10.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 10.12.5 Zosano Pharma Recent Development
  • 13.13 Relmada Therapeutics
    • 10.13.1 Relmada Therapeutics Company Details
    • 10.13.2 Relmada Therapeutics Business Overview
    • 10.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 10.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 10.13.5 Relmada Therapeutics Recent Development
  • 13.14 Eli Lilly and Company
    • 10.14.1 Eli Lilly and Company Company Details
    • 10.14.2 Eli Lilly and Company Business Overview
    • 10.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 10.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 10.14.5 Eli Lilly and Company Recent Development
  • 13.15 Transdermal Specialties
    • 10.15.1 Transdermal Specialties Company Details
    • 10.15.2 Transdermal Specialties Business Overview
    • 10.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
    • 10.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
    • 10.15.5 Transdermal Specialties Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Next Generation Diabetes Therapy and Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Diabetes Therapy and Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Johnson & Johnson
    Abbott Laboratories
    Medtronic
    Sanofi
    Novo Nordisk
    MannKind Corporation
    Enteris BioPharma
    Dexcom
    Senseonics
    Medtech
    Synertech
    Zosano Pharma
    Relmada Therapeutics
    Eli Lilly and Company
    Transdermal Specialties

    Market segment by Type, the product can be split into
    Inhalable Insulin
    Oral Insulin
    Insulin Patches
    CGM Systems
    Artificial Pancreas
    Market segment by Application, split into
    Diagnostic/Clinics
    ICUs
    Home Healthcare

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now